The Peptides And Macrocycle Drug Discovery Services Market Is Projected To Reach USD 1.5 Billion By 2030, Growing At An Annualized Rate Of 10.5%.


The peptides and macrocycle drug discovery services market is projected to reach USD 1.5 Billion by 2030, growing at an annualized rate of 10.5%.

Due to technological advancements in drug discovery, the domain of peptides and macrocycles has once again garnered significant interest from various stakeholders in the recent past.
Roots Analysis has announced the addition of “Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030” report to its list of offerings.
Drug discovery is challenging and involves several complexities. In order to continue to add new molecules their pipelines, drug developers are opting to outsource such operations to contract research organizations (CROs). Outsourcing of peptides and macrocycle drug discovery has emerged as one of the recent trends in the overall pharmaceutical domain.
To order this 180+ page report, which features 90+ figures and 85+ tables, please visit this link
Key Market Insights
Over 25 companies offer peptides and macrocyclic drug discovery services 
The market features a mix of small companies (<50 employees, 43%), mid-sized companies (51 to 500 employees, 36%) and very large and large companies (>500 employees, 21%).
Almost 50% of peptides and macrocycle drug discovery service providers are based in the Europe
Within Europe, most of the players are based in France and Germany. Examples of companies headquartered in the aforementioned regions include (in alphabetical order) 3B Pharmaceuticals, JPT Peptide Technologies, Oncodesign, Prestwick Chemical, Provepharm, and Taros.
More than 85% of the peptides and macrocyclic drug discovery service providers offer lead optimization services
Examples of other peptides and macrocyclic drug discovery services include hit identification, target validation and lead generation. Examples of companies offering all these discovery services include (in alphabetical order) Creative Biolabs, Eurofins, IRBM, Prestwick Chemical and Taros.
Over 25 companies offer peptides and macrocyclic drug discovery platforms
The market is dominated by the presence of start-up companies (having year of establishment post 2000), which represent more than 85% of the competitive landscape. The platform providers established before 2000 are (in alphabetical order) are Hanmi, Oncodesign, Polyphor and Zealand Pharma.
55+ collaboration instances inked between 2015 and 2019
Research collaboration accounted for 51% of the total number of agreements inked between 2015 and 2019, which is followed by Research and development agreements (37%), Licensing agreement (7) and Mergers and Acquisitions (5%). PeptiDream accounted for 41% of the total number of partnership instances. Examples of recent partnerships inked by this company include (in reverse chronological order) joint research agreement with Fujitsu (September 2019), R&D Agreement with Novartis (June 2019) and R&D Agreement with Nihon Medi-Physics (December 2018).
Presently, the largest market share (in terms of peptide discovery step) is captured by lead optimization
Lead optimization captures the highest share of the peptides discovery outsourcing market (51%), followed by lead generation (28%), hit identification (15%) and target validation (6%).
To request a sample copy / brochure of this report, please visit this link
Key Questions Answered

  • Who are the key service providers for peptide discovery?
  • Who are the key service providers for macrocycle drug discovery?
  • Who are the service providers that can synthesize peptide and macrocycle libraries?
  • What is the outsourcing trend in the peptides and macrocycle drug discovery?
  • How is the current and future market opportunity likely to be distributed across key market segments based on the services market?
  • What are the promising technology platforms that are available for the discovery of peptides and macrocyclic drugs?
  • What are the various trends in partnerships and licensing activity in this domain?
  • What are the strengths, weakness, opportunities, and threats in this industry?

Key geographical regions

  • Europe
  • North America
  • Asia-Pacific and the Rest of the World

The report features inputs from eminent industry stakeholders, according to whom peptide and macrocycles drug discovery outsourcing market is continuously pacing up. The report includes detailed transcripts of discussions held with the following experts:

The research covers profiles of key players that offer peptides and macrocyclic drugs discovery platforms and services, featuring an overview of the company, its service portfolio / technology platform, and an informed future outlook.

  • GenScript
  • JPT Peptide Technologies
  • CPC Scientific
  • IRBM
  • Creative Peptides
  • Pepscan
  • Interprotein
  • RA Pharmaceuticals
  • Pepticom
  • PeptiDream
  • Creative Biolabs
  • MeSCue-Janusys

For additional details, please visit discovery/300.html
You may also be interested in the following titles:

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091


Keywords: pharma,biotech,research,rootsanalysis


Other related blogs

The “Prefilled Syringe Fill / Finish Service Providers, 2020-2030” report features an extensive study of the current market

By : Roots Analysis

Key Inclusions A detailed review of the overall landscape of companies offering contract fill / f..

The prefilled syringe fill / finish services market is projected to grow at an annualized rate of over 10%, till 2030

By : Roots Analysis

Roots Analysis has done a detailed study on Prefilled Syringe Fill / Finish Services Market, 2020-20..

The prefilled syringe fill / finish services market is estimated to is estimated to reach close to USD 3 Billion by 2030

By : Roots Analysis

The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, h..